Video 1
Video 2
Video 3
Nodular and cystic acne represent more severe forms of inflammatory acne that develop when blockage and inflammation extend deep within the pilosebaceous unit. Acne begins with excess sebum production and abnormal follicular keratinization, which lead to clogged pores and the formation of microcomedones. In mild cases, these blockages remain superficial and appear as blackheads or whiteheads. In nodular and cystic acne, however, the follicular wall may rupture beneath the skin surface. This rupture allows sebum, keratin, and bacterial byproducts to spill into surrounding tissue, triggering a more intense immune response and deeper inflammation.
Nodules are firm, painful lesions that develop deep within the skin and do not contain visible pus. Cystic lesions are similar in depth but are often softer and may contain fluid or purulent material. Both forms are characterized by significant inflammation and a higher risk of scarring compared with comedonal acne. Because the inflammatory process occurs beneath the surface, these lesions may persist for weeks and are less responsive to surface-level treatments alone.
Several factors contribute to the development of nodular and cystic acne. Elevated androgen activity can increase sebaceous gland size and sebum production, creating a lipid-rich environment within the follicle. Genetic predisposition may influence both oil production and the intensity of the inflammatory response. Individuals with a family history of severe acne may be more likely to experience deep, painful lesions. Hormonal fluctuations during adolescence or adulthood, particularly along the jawline and lower face, can further contribute. Delayed or inadequate treatment of persistent clogged pores may also increase the likelihood that inflammation progresses to deeper layers.
Because of their depth and inflammatory nature, nodular and cystic lesions often require more comprehensive treatment. Topical retinoids remain foundational because they help normalize follicular keratinization and reduce the formation of new clogged pores. Benzoyl peroxide may assist in reducing bacterial overgrowth and limiting inflammatory activity. However, severe nodulocystic acne frequently requires prescription therapies. Dermatologists may consider oral antibiotics for short-term control of inflammation, hormonal treatments when androgen sensitivity is suspected, or oral isotretinoin in appropriately selected cases. Treatment decisions depend on individual severity, medical history, and risk factors.
Protecting the skin barrier remains important even in severe acne. Over-exfoliation or aggressive scrubbing can worsen inflammation and increase discomfort. Gentle cleansing and non-comedogenic moisturizers help maintain barrier integrity while active treatments are used. Niacinamide may support barrier function and reduce visible redness, although it is typically adjunctive rather than primary therapy in nodular acne.
Nodular and cystic acne carry a higher risk of permanent scarring and post-inflammatory hyperpigmentation, making early intervention particularly important. Attempting to squeeze or drain deep lesions can intensify inflammation and increase tissue damage. Individuals experiencing painful, persistent, or widespread nodules should seek evaluation from a qualified dermatology professional. With timely, evidence-informed management, inflammation can often be controlled and the risk of long-term skin changes reduced, though improvement may occur gradually over time
